The current valuation score of Royalty Pharma PLC is 7.01, ranking 140 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 28.25, which is 1325.82% below the recent high of 402.86 and 66.37% above the recent low of 9.50.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.